rosiglitazone has been researched along with androstenedione in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M; Lin, Y; Ma, Y; Zheng, Z | 1 |
| Bayraktar, F; Dereli, D; Dereli, T; Ozgen, AG; Yilmaz, C | 1 |
| Arslan, M; Ayvaz, G; Cakir, N; Karakoç, A; Tiras, B; Törüner, FB; Yilmaz, M | 1 |
3 trial(s) available for rosiglitazone and androstenedione
| Article | Year |
|---|---|
[Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].
Topics: Administration, Oral; Adult; Androstenedione; Blood Glucose; Body Weight; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Lipids; Luteinizing Hormone; Menstruation; Neuropeptide Y; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2002 |
Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease.
Topics: Adult; Androstenedione; Blood Glucose; Body Mass Index; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Glycated Hemoglobin; Hirsutism; Humans; Hypoglycemic Agents; Insulin; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazolidinediones | 2005 |
The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Female; Glucose Tolerance Test; Hirsutism; Humans; Hypoglycemic Agents; Insulin; Menstrual Cycle; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazolidinediones; Treatment Outcome | 2005 |